Protection against ventricular fibrillation via cholinergic receptor stimulation and the generation of nitric oxide.
Implantable cardiac vagal nerve stimulators are a promising treatment for ventricular arrhythmia in patients with heart failure. Animal studies suggest the antifibrillatory effect may be nitric oxide (NO) dependent, although the exact site of action is controversial. We investigated whether a stable...
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
John Wiley and Sons Ltd
2016
|